Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Nanoparticle contrast agents for computed tomography: a focus on micelles.

Cormode DP, Naha PC, Fayad ZA.

Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):37-52. doi: 10.1002/cmmi.1551. Review.

2.

Multicolor computed tomographic molecular imaging with noncrystalline high-metal-density nanobeacons.

Pan D, Schirra CO, Wickline SA, Lanza GM.

Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):13-25. doi: 10.1002/cmmi.1571. Review.

3.

Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications.

Liu Y, Ai K, Lu L.

Acc Chem Res. 2012 Oct 16;45(10):1817-27. doi: 10.1021/ar300150c. Epub 2012 Sep 5. Review.

PMID:
22950890
4.

Iodinated blood pool contrast media for preclinical X-ray imaging applications--a review.

Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T.

Biomaterials. 2010 Aug;31(24):6249-68. doi: 10.1016/j.biomaterials.2010.04.066. Epub 2010 May 26. Review.

PMID:
20510444
5.

Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study.

Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R.

Int J Nanomedicine. 2011;6:2859-64. doi: 10.2147/IJN.S25446. Epub 2011 Nov 11.

6.

Recent advances in ytterbium-based contrast agents for in vivo X-ray computed tomography imaging: promises and prospects.

Liu Y, Liu J, Ai K, Yuan Q, Lu L.

Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):26-36. doi: 10.1002/cmmi.1537. Review.

PMID:
24470292
7.

Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.

Cormode DP, Roessl E, Thran A, Skajaa T, Gordon RE, Schlomka JP, Fuster V, Fisher EA, Mulder WJ, Proksa R, Fayad ZA.

Radiology. 2010 Sep;256(3):774-82. doi: 10.1148/radiol.10092473. Epub 2010 Jul 28.

8.

A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer.

Kim D, Jeong YY, Jon S.

ACS Nano. 2010 Jul 27;4(7):3689-96. doi: 10.1021/nn901877h.

PMID:
20550178
9.

Targeted tumor computed tomography imaging using low-generation dendrimer-stabilized gold nanoparticles.

Liu H, Xu Y, Wen S, Chen Q, Zheng L, Shen M, Zhao J, Zhang G, Shi X.

Chemistry. 2013 May 10;19(20):6409-16. doi: 10.1002/chem.201204612. Epub 2013 Mar 15.

PMID:
23505030
10.

Multifunctional theranostic gold nanoparticles for targeted CT imaging and photothermal therapy.

Curry T, Kopelman R, Shilo M, Popovtzer R.

Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):53-61. doi: 10.1002/cmmi.1563. Review.

PMID:
24470294
11.

Heparin-coated gold nanoparticles for liver-specific CT imaging.

Sun IC, Eun DK, Na JH, Lee S, Kim IJ, Youn IC, Ko CY, Kim HS, Lim D, Choi K, Messersmith PB, Park TG, Kim SY, Kwon IC, Kim K, Ahn CH.

Chemistry. 2009 Dec 14;15(48):13341-7. doi: 10.1002/chem.200902344. No abstract available.

PMID:
19902441
12.

Syntheses and characterization of lisinopril-coated gold nanoparticles as highly stable targeted CT contrast agents in cardiovascular diseases.

Ghann WE, Aras O, Fleiter T, Daniel MC.

Langmuir. 2012 Jul 17;28(28):10398-408. doi: 10.1021/la301694q. Epub 2012 Jul 5.

PMID:
22702239
13.

Gold nanoparticle based X-ray contrast agent for tumor imaging in mice and dog: a potential nano-platform for computer tomography theranostics.

Chanda N, Upendran A, Boote EJ, Zambre A, Axiak S, Selting K, Katti KV, Leevy WM, Afrasiabi Z, Vimal J, Singh J, Lattimer JC, Kannan R.

J Biomed Nanotechnol. 2014 Mar;10(3):383-92.

PMID:
24730234
14.

Large-scale and facile synthesis of biocompatible Yb-based nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.

Liu J, Xin R, Li Z, Golamaully R, Zhang Y, Zhang J, Yuan Q, Liu X.

Curr Top Med Chem. 2013;13(4):513-8. Review.

PMID:
23432013
15.

Nano-sized CT contrast agents.

Lee N, Choi SH, Hyeon T.

Adv Mater. 2013 May 21;25(19):2641-60. doi: 10.1002/adma.201300081. Epub 2013 Apr 4. Review.

PMID:
23553799
16.

An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles.

Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G, Weissleder R.

Nat Mater. 2006 Feb;5(2):118-22. Epub 2006 Jan 29.

PMID:
16444262
17.

Gold nanoparticles provide bright long-lasting vascular contrast for CT imaging.

Au JT, Craig G, Longo V, Zanzonico P, Mason M, Fong Y, Allen PJ.

AJR Am J Roentgenol. 2013 Jun;200(6):1347-51. doi: 10.2214/AJR.12.8933.

PMID:
23701074
18.

Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents.

Jackson PA, Rahman WN, Wong CJ, Ackerly T, Geso M.

Eur J Radiol. 2010 Jul;75(1):104-9. doi: 10.1016/j.ejrad.2009.03.057. Epub 2009 Apr 29.

PMID:
19406594
19.

Gold nanoparticles as contrast agents in x-ray imaging and computed tomography.

Cole LE, Ross RD, Tilley JM, Vargo-Gogola T, Roeder RK.

Nanomedicine (Lond). 2015 Jan;10(2):321-41. doi: 10.2217/nnm.14.171. Review.

PMID:
25600973
20.

AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging.

Aydogan B, Li J, Rajh T, Chaudhary A, Chmura SJ, Pelizzari C, Wietholt C, Kurtoglu M, Redmond P.

Mol Imaging Biol. 2010 Oct;12(5):463-7. doi: 10.1007/s11307-010-0299-8.

PMID:
20237857
Items per page

Supplemental Content

Write to the Help Desk